Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,415 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Applicant's Unreasonable Delays During Patent Prosecution Can Lead To Prosecution Laches

    In Hyatt v. Hirshfeld, No. 2018-2390 (Fed. Cir. June 1, 2021), the Federal Circuit vacated and remanded the district court's rejection of the PTO's arguments for prosecution laches.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Podcast

    April 2023 - Last Month At The Federal Circuit Podcast Series (Podcast)

    Welcome to the Last Month at the Federal Circuit. In this episode, Finnegan attorneys Jason Romrell and Ryan McDonnell discuss amendments to the Federal Circuit Rules...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Are You In The Sports IP Game? Protecting Your IP With Patents And Trade Secrets

    In the sports and fitness industry, a thoroughly developed intellectual property (IP) strategy may not only help launch a company but also enable it to develop into a profitable and successful competitor in a fairly saturated marketplace.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    CAFC Holds Medical Device Claims Patent Eligible In

    In CardioNet, LLC v. InfoBionic, Inc., No. 2019-1149 (Fed. Cir. Apr. 17, 2020), the Federal Circuit reversed the district court's determination that the claims covering a device for monitoring ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Certain Patent Activity Is Sufficient To Confer U.S. Jurisdiction Over Foreign Entity

    In Genetic Veterinary Sciences, Inc. v. Laboklin GMBH & Co. KG, No. 2018-2056 (Fed. Cir. Aug. 9, 2019), the Federal Circuit affirmed the district court's determination that certain asserted claims
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Changes To USPTO Patent Fees For 2025

    Effective January 19, 2025, the United States Patent and Trademark Office (USPTO) will implement significant changes to patent fees following the last review in fiscal year 2021.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Claim Language Could Limit Design Patent Where Specific Article Of Manufacture Not Shown In Figures

    In Curver Luxembourg, SARL v. Home Expressions Inc., No. 2018-2214 (Fed. Cir. Sep. 12, 2019), the Federal Circuit held claim language could limit the scope of a design
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Copyright Office Announces Music Licensing Study

    The Copyright Office announced that it is undertaking a study to assess the efficacy of current music licensing schemes.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Distribution Agreement Constitutes An "Offer For Sale" Under Pre-AIA 35 U.S.C.

    Following the court's en banc decision that a contract manufacturing arrangement did not give rise to an on-sale bar, the Medicines Co. v. Hospira, Inc. appeal returned to the original Federal Circuit panel ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Does The "Broadest Reasonable Interpretation" Claim Construction Standard Apply To Means-Plus-Function Claim Terms In AIA Trials?

    For the last three years, America Invents Act (AIA) trials before the Patent Trial and Appeal Board (Board) have been effective tools for challenging the validity of issued patents.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Drafting For Multiple Jurisdictions Miniseries Part III: Mind Your Language!

    Many patent owners are interested in trying to draft a single patent application that will serve them in several countries. This is ambitious, since there are many differences ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    EPO Technical Board Of Appeal Decides Not To Refer Questions To The Enlarged Board Of Appeal Regarding Description Amendments

    In a much-awaited decision, Technical Board of Appeal 3.3.04, in T 56/21, has not referred questions to the Enlarged Board of Appeal on the requirement for applicants to amend...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Expenses Under 35 U.S.C. § 145 Does Not Include Attorneys' Fees

    In Nantkwest, Inc. v. Iancu, No. 2016-1794 (Fed. Cir. July 27, 2018), the Federal Circuit, sitting en banc (excl. Chen, C.J.), affirmed the district court's decision ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Affirms Noninfringement Where Expert's Analysis Of Means-Plus-Function Claim Failed To Account For Disclosed Structure

    In Genuine Enabling Technology LLC v. Sony Group Corp., No. 24-1686 (Fed. Cir. Feb. 19, 2026), the Federal Circuit affirmed summary judgment of noninfringement, emphasizing that patentees' infringement...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Clarifies That There Is Not A Heightened Standard For Willful Infringement

    In SRI Int'l, Inc. v. Cisco Sys., Inc., No. 2020-1685 (Fed. Cir. Sept. 28, 2021), the Federal Circuit reinstated the jury's willful infringement verdict and restored the district court's award of enhanced damages.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Holds § 285 Applies To Exceptional Cases, Not Exceptional Portions Of Cases

    In Intellectual Ventures I LLC v. Trend Micro Inc., No. 2019-1122 (Fed. Cir. Dec. 19, 2019), the Federal Circuit remanded the district court's award of fees under 35 U.S.C. § 285, holding that...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit KOs Gaming Patent

    In Bot M8 LLC v. Sony Interactive Entertainment LLC, No. 22-1291 (Fed. Cir. May 9, 2023), the Federal Circuit affirmed a final written decision from the Patent Trial and Appeal Board...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Reaffirms Burdens Of Proof Between IPR And District Court

    In Inland Diamond Products Co. v. Cherry Optical Inc., No. 2024-1106 (Fed. Cir. Oct. 15, 2025), the Federal Circuit determined the district court's grant of summary judgment based on issue...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Rejects PTAB's Analysis Of Secondary Considerations Of Nonobviousness

    In Volvo Penta of the Americas, LLC v. Brunswick Corporation, No. 22-1765 (Fed. Cir. Aug. 24, 2023), the Federal Circuit vacated and remanded PTAB's holding that all claims of U.S. Patent 9,630,692 are unpatentable as obvious.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Federal Circuit Sidesteps Determination Of Generics' Skinny Label As Protection Against Induced Infringement

    In a per curiam order, GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., Nos. 2018-1976, 2018-2023 (Fed. Cir. Feb. 11, 2022), the Federal Circuit denied Teva's petition for rehearing en banc of the panel decision, ...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Showing 701–720 of 4415 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics